Haemonetics Corp. buy Barrington Research
Start price
08.11.24
/
50%
€80.50
Target price
08.11.25
€100.71
Performance (%)
-19.88%
Price
06.08.25
€64.50
Summary
This prediction is currently active. The price of Haemonetics Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.88%. This prediction currently runs until 08.11.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Haemonetics Corp. | 0.781% | 0.781% |
iShares Core DAX® | 0.683% | 0.785% |
iShares Nasdaq 100 | -1.457% | 3.734% |
iShares Nikkei 225® | 0.931% | 2.958% |
iShares S&P 500 | -2.022% | 2.444% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Barrington_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€91.64
07.02.26
07.02.26
13.16%
06.08.25
06.08.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€78.50
04.12.24
04.12.24
€102.93
04.12.25
04.12.25
-17.83%
06.08.25
06.08.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€68.00
23.09.24
23.09.24
€97.01
23.09.25
23.09.25
-5.88%
06.08.25
06.08.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€88.50
10.05.24
10.05.24
€99.33
10.05.25
10.05.25
-29.38%
11.05.25
11.05.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€78.50
12.04.24
12.04.24
€98.71
12.04.25
12.04.25
-34.39%
13.04.25
13.04.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.00
13.02.24
13.02.24
€97.90
13.02.25
13.02.25
-11.36%
14.02.25
14.02.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€81.50
03.11.23
03.11.23
€97.80
03.11.24
03.11.24
-18.40%
04.11.24
04.11.24